EDNRB and atherosclerosis: Our data contrast with other animal studies demonstrating that either dual ETA/ETB or selective ETA receptor antagonists reduce the development and progression of atherosclerosis in both Western diet-fed ApoE−/− and Ldlr-/–deficient mice.42, , –45 .